1. Home
  2. NEPH vs RNXT Comparison

NEPH vs RNXT Comparison

Compare NEPH & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • RNXT
  • Stock Information
  • Founded
  • NEPH 1997
  • RNXT 2012
  • Country
  • NEPH United States
  • RNXT United States
  • Employees
  • NEPH N/A
  • RNXT N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • RNXT Health Care
  • Exchange
  • NEPH Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • NEPH 45.3M
  • RNXT 44.6M
  • IPO Year
  • NEPH 2004
  • RNXT 2021
  • Fundamental
  • Price
  • NEPH $4.31
  • RNXT $1.25
  • Analyst Decision
  • NEPH Strong Buy
  • RNXT Strong Buy
  • Analyst Count
  • NEPH 2
  • RNXT 2
  • Target Price
  • NEPH $5.50
  • RNXT $7.50
  • AVG Volume (30 Days)
  • NEPH 45.8K
  • RNXT 626.0K
  • Earning Date
  • NEPH 11-06-2025
  • RNXT 11-12-2025
  • Dividend Yield
  • NEPH N/A
  • RNXT N/A
  • EPS Growth
  • NEPH N/A
  • RNXT N/A
  • EPS
  • NEPH 0.12
  • RNXT N/A
  • Revenue
  • NEPH $16,684,000.00
  • RNXT $662,000.00
  • Revenue This Year
  • NEPH $24.38
  • RNXT $2,988.37
  • Revenue Next Year
  • NEPH $10.16
  • RNXT $300.60
  • P/E Ratio
  • NEPH $36.92
  • RNXT N/A
  • Revenue Growth
  • NEPH 21.16
  • RNXT N/A
  • 52 Week Low
  • NEPH $1.36
  • RNXT $0.75
  • 52 Week High
  • NEPH $5.00
  • RNXT $1.69
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 57.06
  • RNXT 58.60
  • Support Level
  • NEPH $3.62
  • RNXT $1.19
  • Resistance Level
  • NEPH $4.94
  • RNXT $1.45
  • Average True Range (ATR)
  • NEPH 0.39
  • RNXT 0.12
  • MACD
  • NEPH 0.01
  • RNXT 0.03
  • Stochastic Oscillator
  • NEPH 54.55
  • RNXT 60.76

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: